Daniel Nicastri, MD

Gynecologic oncology combines aspects of medicine that I love—the ability to get to know patients and keep up with them for a long time, while helping them to move past illness. The field gives me the chance to work closely with colleagues, role models and trainees, and the science and surgical aspects of gynecologic oncology are dynamic and elegant—advances are made daily. The field has changed immensely, even since I was in medical school, with women living longer and better than ever before.

I am a surgeon who specializes in the care and treatment of patients with breast cancer, and those at increased risk for breast cancer. I have extensive experience with sentinel lymph node biopsy, nipple sparing mastectomy, and the newest techniques in breast cancer surgery for both invasive breast cancer and DCIS. I am the author of a variety of publications on the role of sentinel lymph node biopsy in breast cancer, the role of MRI in patients at high risk for breast cancer, and I have received a Komen Foundation Grant investigating the role of PET scanning in breast cancer. I recently completed an NCI funded clinical trial investigating the effects of the COX2 inhibitor, Celebrex, on breast cancer tissue. I am a member of many professional organizations including the Society of Surgical Oncology, the American Society of Breast Diseases, the American Society of Breast Surgeons, and the American College of Surgeons Oncology Group.

Israel Kochin, MD is a Pediatrics provider with Mount Sinai Health System, treating patients in the New York area. Dr. Kochin is committed to compassionate, coordinated care that supports patients throughout the diverse communities we serve.